NCT06710587View on ClinicalTrials.gov

Does Use of the Voy Program Improve Weight Loss Percentage and Other Health Outcomes in a Population Already Taking GLP/GIP-1RA Medication?

NANot yet recruitingINTERVENTIONAL
Enrollment

470

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

April 2, 2026

Study Completion Date

April 2, 2027

Conditions
ObesityWeight Loss
Interventions
BEHAVIORAL

Voy Program

Voy Program - coaching and access to the Voy app to support behavioural changes

Sponsors

Collaborators (1)

Lindus Health
All Listed Sponsors
collaborator

Lindus Health

INDUSTRY

lead

Menwell Limited

INDUSTRY

NCT06710587 - Does Use of the Voy Program Improve Weight Loss Percentage and Other Health Outcomes in a Population Already Taking GLP/GIP-1RA Medication? | Biotech Hunter | Biotech Hunter